An up­start im­munother­a­py biotech emerges from stealth mode with big love for Kendall Square

When Ron Sei­del and Rodol­fo “Rudy” Chap­ar­ro had to sit down and de­cide where to base their new biotech, the two in­ves­ti­ga­tors at Al­bert Ein­stein …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.